KIT and acral lentiginous melanoma: Population-level studies estimate that approximately 11–23% of acral melanomas, 15–21% of mucosal melanomas, and up to 27% of CSD melanomas harbor KIT mutations, whereas the prevalence in non-CSD cutaneous melanoma is generally less than 5% [7,10,12,13].